Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1989 Feb;57(2):513–519. doi: 10.1128/iai.57.2.513-519.1989

Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities.

J E Wolf 1, A L Abegg 1, S J Travis 1, G S Kobayashi 1, J R Little 1
PMCID: PMC313126  PMID: 2912897

Abstract

Histoplasma capsulatum yeast cells fail to trigger an oxidative burst response in normal murine macrophages. The results of this study, in which an in vitro assay of macrophage antifungal effects was used, extend these findings. During 18 h of incubation, unprimed elicited murine macrophages inhibited H. capsulatum growth only when macrophages were present in great excess. Gamma interferon (IFN-gamma)-primed macrophages showed enhanced fungal growth inhibition but a similar requirement for an excess of phagocytes. Macrophages containing heat-killed H. capsulatum exhibited diminished antifungal effects toward viable H. capsulatum and Saccharomyces cerevisiae cells. Parallel experiments showed no comparable effect of ingested latex particles on macrophage antifungal activity. Using chemiluminescence as a measure of the oxidative burst, we found that macrophages primed in vitro with IFN-gamma alone failed to exhibit a significant response to triggering by H. capsulatum yeast cells unless a second priming agent (tumor necrosis factor alpha or bacterial lipopolysaccharide) was added to IFN-gamma. Furthermore, macrophage priming with single agents was blocked by the prior ingestion of heat-killed H. capsulatum. These studies provide evidence that ingestion of H. capsulatum yeast cells can induce a prompt and enduring deactivation of murine macrophages.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Hamilton T. A. The cell biology of macrophage activation. Annu Rev Immunol. 1984;2:283–318. doi: 10.1146/annurev.iy.02.040184.001435. [DOI] [PubMed] [Google Scholar]
  2. Buchmüller-Rouiller Y., Mauël J. Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect Immun. 1987 Mar;55(3):587–593. doi: 10.1128/iai.55.3.587-593.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bullock W. E., Wright S. D. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med. 1987 Jan 1;165(1):195–210. doi: 10.1084/jem.165.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Channon J. Y., Roberts M. B., Blackwell J. M. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology. 1984 Oct;53(2):345–355. [PMC free article] [PubMed] [Google Scholar]
  5. Charnetzky W. T., Shuford W. W. Survival and growth of Yersinia pestis within macrophages and an effect of the loss of the 47-megadalton plasmid on growth in macrophages. Infect Immun. 1985 Jan;47(1):234–241. doi: 10.1128/iai.47.1.234-241.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Decker T., Lohmann-Matthes M. L., Baccarini M. Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans. Infect Immun. 1986 Nov;54(2):477–486. doi: 10.1128/iai.54.2.477-486.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ding A. H., Nathan C. F. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity. J Immunol. 1987 Sep 15;139(6):1971–1977. [PubMed] [Google Scholar]
  8. Djeu J. Y., Blanchard D. K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol. 1986 Nov 1;137(9):2980–2984. [PubMed] [Google Scholar]
  9. Djeu J. Y., Parapanissios A., Halkias D., Friedman H. A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods. 1986 Aug 21;92(1):73–77. doi: 10.1016/0022-1759(86)90505-3. [DOI] [PubMed] [Google Scholar]
  10. Eissenberg L. G., Goldman W. E. Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect Immun. 1987 Jan;55(1):29–34. doi: 10.1128/iai.55.1.29-34.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Granger D. L., Perfect J. R., Durack D. T. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol. 1986 Jan;136(2):672–680. [PubMed] [Google Scholar]
  12. Holzer T. J., Nelson K. E., Crispen R. G., Andersen B. R. Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation. Infect Immun. 1986 Feb;51(2):514–520. doi: 10.1128/iai.51.2.514-520.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ito M., Karmali R., Krim M. Effect of interferon on chemiluminescence and hydroxyl radical production in murine macrophages stimulated by PMA. Immunology. 1985 Nov;56(3):533–541. [PMC free article] [PubMed] [Google Scholar]
  14. Jacobson E. S., Harrell A. C. Cysteine-independent and cysteine-requiring yeast-strains of Histoplasma capsulatum. Mycopathologia. 1982 Feb 19;77(2):69–73. doi: 10.1007/BF00437386. [DOI] [PubMed] [Google Scholar]
  15. Klimpel K. R., Goldman W. E. Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum. Infect Immun. 1987 Mar;55(3):528–533. doi: 10.1128/iai.55.3.528-533.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kumar B. V., Medoff G., Kobayashi G. S., Sieling W. L. Cross-reacting human and rabbit antibodies to antigens of Histoplasma capsulatum, Candida albicans, and Saccharomyces cerevisiae. Infect Immun. 1985 Jun;48(3):806–812. doi: 10.1128/iai.48.3.806-812.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lepay D. A., Nathan C. F., Steinman R. M., Murray H. W., Cohn Z. A. Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J Exp Med. 1985 May 1;161(5):1079–1096. doi: 10.1084/jem.161.5.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Locksley R. M., Fankhauser J., Henderson W. R. Alteration of leukotriene release by macrophages ingesting Toxoplasma gondii. Proc Natl Acad Sci U S A. 1985 Oct;82(20):6922–6926. doi: 10.1073/pnas.82.20.6922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mauël J., Buchmüller-Rouiller Y. Effect of lipopolysaccharide on intracellular killing of Leishmania enriettii and correlation with macrophage oxidative metabolism. Eur J Immunol. 1987 Feb;17(2):203–208. doi: 10.1002/eji.1830170209. [DOI] [PubMed] [Google Scholar]
  20. Murray H. W., Cohn Z. A. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J Exp Med. 1980 Dec 1;152(6):1596–1609. doi: 10.1084/jem.152.6.1596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nathan C. F., Murray H. W., Cohn Z. A. The macrophage as an effector cell. N Engl J Med. 1980 Sep 11;303(11):622–626. doi: 10.1056/NEJM198009113031106. [DOI] [PubMed] [Google Scholar]
  22. Pearson R. D., Harcus J. L., Symes P. H., Romito R., Donowitz G. R. Failure of the phagocytic oxidative response to protect human monocyte-derived macrophages from infection by Leishmania donovani. J Immunol. 1982 Sep;129(3):1282–1286. [PubMed] [Google Scholar]
  23. Simon L. M., Robin E. D., Phillips J. R., Acevedo J., Axline S. G., Theodore J. Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2. J Clin Invest. 1977 Mar;59(3):443–448. doi: 10.1172/JCI108658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stevens P., Winston D. J., Van Dyke K. In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states. Infect Immun. 1978 Oct;22(1):41–51. doi: 10.1128/iai.22.1.41-51.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sun D., Lohmann-Matthes M. L. Functionally different subpopulations of mouse macrophages recognized by monoclonal antibodies. Eur J Immunol. 1982 Feb;12(2):134–140. doi: 10.1002/eji.1830120207. [DOI] [PubMed] [Google Scholar]
  26. Tsunawaki S., Nathan C. F. Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium. J Exp Med. 1986 Oct 1;164(4):1319–1331. doi: 10.1084/jem.164.4.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wilson C. B., Tsai V., Remington J. S. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med. 1980 Feb 1;151(2):328–346. doi: 10.1084/jem.151.2.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wolf J. E., Kerchberger V., Kobayashi G. S., Little J. R. Modulation of the macrophage oxidative burst by Histoplasma capsulatum. J Immunol. 1987 Jan 15;138(2):582–586. [PubMed] [Google Scholar]
  29. Wu-Hsieh B., Howard D. H. Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages. J Immunol. 1984 May;132(5):2593–2597. [PubMed] [Google Scholar]
  30. Wu-Hsieh B., Zlotnik A., Howard D. H. T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum. Infect Immun. 1984 Jan;43(1):380–385. doi: 10.1128/iai.43.1.380-385.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES